Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by L. Li Wang
The Criteria of Interim Therapy Change for Patients With Diffuse Large B-Cell Lymphoma: Interim Δspd Less Than 80% vs. 50%
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Decitabine Plus R-Chop in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma: Interim Results of a Phase I/Ii Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Interim [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Based Chemotherapy Plus Rituximab
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Preliminary Results of a Phase II Study Using Response-Adapted Therapy for Limited-Stage Diffuse Large B-Cell Lymphoma Based on Interim PET/CT
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Global Pivotal Phase 2 Trial of the Cd19-Targeted Therapy Ctl019 in Adult Patients With Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (Dlbcl)-An Interim Analysis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Diffuse Large B-Cell Lymphoma
Circulating Cell-Free miR-494 and miR-21 Are Disease Response Biomarkers Associated With Interim-Positron Emission Tomography Response in Patients With Diffuse Large B-Cell Lymphoma
Oncotarget
Oncology
Is Radiotherapy Still Necessary for Diffuse Large B-Cell Lymphoma Therapy?
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Sandoz Rituximab for Treatment of Diffuse Large B-Cell Lymphoma: Interim Safety Results of the Non-Interventional, Observational, Multicenter, Open-Label Reflect Study
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Efficacy and Tolerability of Anthracycline-Based Therapy in Elderly Patients With Diffuse Large B-Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
